Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
- 1 April 2008
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 13 (4) , 365-373
- https://doi.org/10.1016/j.ccr.2008.02.019
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Receptor tyrosine kinases: mechanisms of activation and signalingPublished by Elsevier ,2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorPublished by Elsevier ,2006
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabPublished by Elsevier ,2005
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004
- EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain DimerizationPublished by Elsevier ,2003
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor αCell, 2002
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997
- Shape Complementarity at Protein/Protein InterfacesJournal of Molecular Biology, 1993